Question 1

Has Rhoda Lyn Aure, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,040 in general payments to Rhoda Lyn Aure, MD across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Rhoda Lyn Aure, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Rhoda Lyn Aure, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
OPKO Pharmaceuticals, LLC	11	$158
Bayer	8	$138
GSK	6	$134
Calliditas Therapeutics US Inc.	5	$113
Vifor Pharma, Inc.	5	$76
Akebia Therapeutics Inc	4	$63
Amgen	3	$56
Mallinckrodt Hospital Products Inc.	3	$48
Otsuka America Pharmaceutical, Inc.	2	$46
AstraZeneca	3	$40
Daiichi Sankyo Inc.	2	$33
Ultragenyx Pharmaceutical Inc.	2	$32
Travere Therapeutics, Inc.	1	$31
Aurinia Pharma U.S., Inc.	2	$29
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$16
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$15
Renalytix AI, Inc.	1	$13

Rhoda Lyn Aure, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other nephrology in Eglin Afb